Webcast / Audiocast

0 Comments

9 December 2016

HEAT-PPCI and BRIGHT

Dr Nick Cruden

Discussing trials comparing Bivalirudin and Heparin inn ACS
Video and Audio streaming
MP3 podcast available for download

Previous | Next
Download

HEAT-PPCI and BRIGHT

Dr Nick Cruden presents a trial update on HEAT-PPCI and BRIGHT.

Both trials investigated the optimal anti-thrombotic strategy, specifically heparin and bivalirudin.

In HEAT-PPCI (Liverpool), a single-centre open label RCT recruited patients with STEMI and they were randomised to either bivalirudin or heparin. This study favoured heparin use over bivalirudin from a reduction in primary composite endpoint, driven by a reduction in re-infarction due to acute stent thrombosis.

The BRIGHT Trial (China), a multi-centre open label RCT enrolled patients with ACS (predominantly STEMI) randomised patients to either bivalirudin (± tirofiban) or heparin (± tirofiban) or heparin + tirofiban. The authors found a reduction in composite endpoint favouring bivalirudin driven by a reduction in bleeding.

Dr Cruden attempts to reconcile these divergent findings.

Download

HEAT-PPCI and BRIGHT

Dr Nick Cruden presents a trial update on HEAT-PPCI and BRIGHT.

Both trials investigated the optimal anti-thrombotic strategy, specifically heparin and bivalirudin.

In HEAT-PPCI (Liverpool), a single-centre open label RCT recruited patients with STEMI and they were randomised to either bivalirudin or heparin. This study favoured heparin use over bivalirudin from a reduction in primary composite endpoint, driven by a reduction in re-infarction due to acute stent thrombosis.

The BRIGHT Trial (China), a multi-centre open label RCT enrolled patients with ACS (predominantly STEMI) randomised patients to either bivalirudin (± tirofiban) or heparin (± tirofiban) or heparin + tirofiban. The authors found a reduction in composite endpoint favouring bivalirudin driven by a reduction in bleeding.

Dr Cruden attempts to reconcile these divergent findings.

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In